Trial Profile
A Phase II Study of R-CHOP With Intensive CNS Prophylaxis and Scrotal Irradiation in Patients With Primary Testicular Diffuse Large B-cell Lymphoma
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Mar 2023
Price :
$35
*
At a glance
- Drugs Cytarabine (Primary) ; Methotrexate (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma; Testicular cancer
- Focus Adverse reactions; Therapeutic Use
- 09 Mar 2023 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.
- 11 Feb 2020 Planned End Date changed from 1 Dec 2019 to 1 Dec 2022.
- 28 Feb 2019 Planned primary completion date changed from 1 Dec 2017 to 1 Jun 2019.